Develops a mass cytometry platform to enhance profiling of T cell activation and cytokine responses, indicating significant improvements in immune monitoring.
Accurate profiling of antigen-specific T cells by measuring T cell activation markers and cytokine production has been limited by inconsistent marker usage across studies and substantial methodological variability. To overcome these challenges, we established a unified mass cytometry (CyTOF) platform that integrates optimized activation-induced marker (AIM) panels, intracellular cytokine staining (ICS), and a cadmium-based barcoding system for high-throughput, multiplexed analysis of T cell responses. We optimized stimulation conditions (18-24 h) and validated highly sensitive dual AIM combinations, including CD25⁺CD134⁺ and CD25⁺CD69⁺ in CD4⁺ T cells, as well as CD25⁺CD137⁺ and CD25⁺CD69⁺ in CD8⁺ T cells. These combinations were stable under protein transport inhibition and closely paralleled cytokine-producing populations. In addition, we developed a cadmium-tagged β2 M/CD298 barcoding strategy that supports 21-plex sample processing without signal distortion. Validation in two independent cohorts confirmed the platform's high sensitivity, reproducibility, and its ability to simultaneously detect AIM⁺ T cells and cytokine-producing subsets. Together, this integrated workflow provides a robust and scalable framework for comprehensive immune monitoring in vaccine development and infectious disease research.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: